| Long name | CD36 Primary Polyclonal Antibody |
| Also known as | CD36 PAb |
| Category | Primary Antibodies |
| Conjugation | Unconjugated |
| Target Antigen | CD36 |
| Specificity | This is a highly specific antibody against CD36 |
| Modification(s) | None |
| Modification site(s) | Unmodified antibody |
| Clonality | Polyclonal antibody |
| Clone number | Polyclonal antibody |
| Concentration | 1ug per 1ul |
| Immunogen range | 50-100/472 |
| Subcellular location | Extracellular |
| Source | KLH conjugated synthetic peptide derived from mouse CD36 |
| Gene ID number | 12491 |
| Swiss Prot | Q08857 |
| Tested Applications | FCM, IF(IHC-P), IHC-P, WB |
| Recommended dilutions | FCM(1:20-100), IF(IHC-P)(1:50-200), IHC-P(1:100-500), WB(1:100-1000) |
| Cross reactivity | Rat, Mouse |
| Cross reactive species details | not every possible cross-reactivity is known, Due to limited amount of testing and knowledge |
| Background of the target antigen | As a coreceptor for TLR4-TLR6, Binds long chain fatty acids and may function in the transport and/or as a regulator of fatty acid transport (By similarity), CXCL2 and CCL9 cytokines, Directly mediates cytoadherence of Plasmodium falciparum parasitized erythrocytes, May function as a cell adhesion molecule, Receptor for thombospondins, THBS1 AND THBS2, Upon ligand binding, and CCL5 cytokine, anionic phospholipids and oxidized low-density lipoprotein (oxLDL), as well as IL1B secretion, leading to the NF-kappa-B-dependent production of CXCL1, mediating their antiangiogenic effects (By similarity), promotes inflammation in monocytes/macrophages, rapidly induces the formation of a heterodimer of TLR4 and TLR6, such as oxLDL or amyloid-beta 42 binding, thrombospondin, via MYD88 signaling pathway, via TICAM1 signaling pathway, which is internalized and triggers inflammatory signals, Binds to collagen |
| Purification method | This antibody was purified via Protein A |
| Storage conditions | 50% glycerol and 0, Store at -20°, 09% sodium azide, C for up to 1 year, Keep the antibody in aqueous buffered solution containing 1% BSA |
| Synonym names | CD36, GPIIIB, GPIV, Glycoprotein IIIb, PAS IV, PAS-4, Platelet glycoprotein 4, Platelet glycoprotein IV, Scarb3, FAT |
| Properties | C, C for long term storage and for short term at + 5°, If you buy Antibodies supplied by Bioss Primary Unconjugated Antibodies they should be stored frozen at - 24° |
| Gene target | CD36 |
| Short name | CD36 Antibody |
| Technique | antibodies against human proteins, antibodies for, Antibody |
| Alternative name | CD36 molecule (thrombospondin receptor) (Antibody to) |
| Alternative technique | antibodies |
| Alternative to gene target | BDPLT10 and CHDS7 and FAT and GP3B and GP4 and GPIV and PASIV and SCARB3, CD36 and IDBG-24023 and ENSG00000135218 and 948, Cd36 and IDBG-136838 and ENSMUSG00000002944 and 12491, Extracellular, TAP-dependent and biological process this GO :0002576 and platelet degranulation and biological process this GO :0002755 and MyD88-dependent toll-like receptor signaling pathway and biological process this GO :0005041 and low-density lipoprotein receptor activity and molecular function this GO :0005515 and protein binding and molecular function this GO :0005615 and extracellular space and cellular component this GO :0005794 and this GO lgi apparatus and cellular component this GO :0005886 and plasma membrane and cellular component this GO :0005887 and integral component of plasma membrane and cellular component this GO :0006629 and lipid metabolic process and biological process this GO :0006898 and receptor-mediated endocytosis and biological process this GO :0006910 and pha this GO cytosis, engulfment and biological process this GO :0060907 and positive regulation of macrophage cytokine production and biological process this GO :0070053 and thrombospondin receptor activity and molecular function this GO :0070892 and lipoteichoic acid receptor activity and molecular function this GO :0071221 and cellular response to bacterial lipopeptide and biological process this GO :0071222 and cellular response to lipopolysaccharide and biological process this GO :0071223 and cellular response to lipoteichoic acid and biological process this GO :0071447 and cellular response to hydroperoxide and biological process this GO :0071813 and lipoprotein particle binding and molecular function this GO :2000121 and regulation of removal of superoxide radicals and biological process this GO :2000334 and positive regulation of blood microparticle formation and biological process this GO :2000379 and positive regulation of reactive oxygen species metabolic process and biological process, lipoprotein particle binding, recognition and biological process this GO :0007155 and cell adhesion and biological process this GO :0007166 and cell surface receptor signaling pathway and biological process this GO :0007263 and nitric oxide mediated signal transduction and biological process this GO :0007596 and blood coagulation and biological process this GO :0008035 and high-density lipoprotein particle binding and molecular function this GO :0008289 and lipid binding and molecular function this GO :0009897 and external side of plasma membrane and cellular component this GO :0009986 and cell surface and cellular component this GO :0010629 and negative regulation of gene expression and biological process this GO :0010744 and positive regulation of macrophage derived foam cell differentiation and biological process this GO :0010886 and positive regulation of cholesterol storage and biological process this GO :0015911 and plasma membrane long-chain fatty acid transport and biological process this GO :0016020 and membrane and cellular component this GO :0016021 and integral component of membrane and cellular component this GO :0019915 and lipid storage and biological process this GO :0019934 and cGMP-mediated signaling and biological process this GO :0030168 and platelet activation and biological process this GO :0030169 and low-density lipoprotein particle binding and molecular function this GO :0030194 and positive regulation of blood coagulation and biological process this GO :0030301 and cholesterol transport and biological process this GO :0030666 and endocytic vesicle membrane and cellular component this GO :0031092 and platelet alpha granule membrane and cellular component this GO :0032735 and positive regulation of interleukin-12 production and biological process this GO :0032755 and positive regulation of interleukin-6 production and biological process this GO :0032760 and positive regulation of tumor necrosis factor production and biological process this GO :0034134 and toll-like receptor 2 signaling pathway and biological process this GO :0034142 and toll-like receptor 4 signaling pathway and biological process this GO :0034381 and plasma lipoprotein particle clearance and biological process this GO :0034383 and low-density lipoprotein particle clearance and biological process this GO :0035634 and response to stilbenoid and biological process this GO :0038123 and toll-like receptor TLR1:TLR2 signaling pathway and biological process this GO :0038124 and toll-like receptor TLR6:TLR2 signaling pathway and biological process this GO :0042590 and antigen processing and presentation of exogenous peptide antigen via MHC class I and biological process this GO :0042953 and lipoprotein transport and biological process this GO :0042992 and negative regulation of transcription factor import into nucleus and biological process this GO :0043123 and positive regulation of I-kappaB kinase/NF-kappaB signaling and biological process this GO :0043277 and apoptotic cell clearance and biological process this GO :0043410 and positive regulation of MAPK cascade and biological process this GO :0044130 and negative regulation of growth of symbiont in host and biological process this GO :0044255 and cellular lipid metabolic process and biological process this GO :0044281 and small molecule metabolic process and biological process this GO :0044539 and long-chain fatty acid import and biological process this GO :0045087 and innate immune response and biological process this GO :0045121 and membrane raft and cellular component this GO :0045335 and pha this GO cytic vesicle and cellular component this GO :0050431 and transforming growth factor beta binding and molecular function this GO :0050731 and positive regulation of peptidyl-tyrosine phosphorylation and biological process this GO :0050830 and defense response to Gram-positive bacterium and biological process this GO :0055096 and low-density lipoprotein particle mediated signaling and biological process this GO :0060100 and positive regulation of pha this GO cytosis, this GO :0000122 and negative regulation of transcription from RNA polymerase II promoter and biological process this GO :0001954 and positive regulation of cell-matrix adhesion and biological process this GO :0002221 and pattern recognition receptor signaling pathway and biological process this GO :0002224 and toll-like receptor signaling pathway and biological process this GO :0002474 and antigen processing and presentation of peptide antigen via MHC class I and biological process this GO :0002479 and antigen processing and presentation of exogenous peptide antigen via MHC class I, this GO :0005041: low-density lipoprotein receptor activity, this GO :0005041: low-density lipoprotein receptor activity and also this GO :0005515: protein binding and also this GO :0008035: high-density lipoprotein particle binding and also this GO :0008289: lipid binding and also this GO :0030169: low-density lipoprotein particle binding and also this GO :0050431: transforming growth factor beta binding and also this GO :0070053: thrombospondin receptor activity and also this GO :0070892: lipoteichoic acid receptor activity and also this GO :0071813: lipoprotein particle binding, this GO :0005515: protein binding, this GO :0008035: high-density lipoprotein particle binding, this GO :0008289: lipid binding, this GO :0030169: low-density lipoprotein particle binding, this GO :0050431: transforming growth factor beta binding, this GO :0070053: thrombospondin receptor activity, this GO :0070892: lipoteichoic acid receptor activity, this GO :0071813: lipoprotein particle binding, CD36 molecule (thrombospondin receptor) |
| Identity | 1663 |
| Gene | CD36 |
| Long gene name | CD36 molecule |
| Synonyms gene name | CD36 antigen (collagen type I receptor, thrombospondin receptor) CD36 molecule (thrombospondin receptor) |
| Synonyms | SCARB3 GPIV FAT GP4 GP3B |
| Locus | 7q21, 11 |
| Discovery year | 1993-06-04 |
| GenBank acession | Z32770 |
| Entrez gene record | 948 |
| Pubmed identfication | 7503937 |
| RefSeq identity | NM_001001547 |
| Classification | CD molecules Scavenger receptors |
| Havana BLAST/BLAT | OTTHUMG00000155383 |
Technique
Supplier
Species
Label
Iso Type
Host
Tissue